Retirement Systems of Alabama cut its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 53.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 192,704 shares of the healthcare conglomerate’s stock after selling 217,419 shares during the quarter. Retirement Systems of Alabama’s holdings in UnitedHealth Group were worth $63,614,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in the stock. Capital World Investors boosted its position in shares of UnitedHealth Group by 18.8% in the third quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock valued at $7,516,107,000 after acquiring an additional 3,439,182 shares during the period. Capital International Investors lifted its stake in UnitedHealth Group by 11.1% in the 3rd quarter. Capital International Investors now owns 17,499,949 shares of the healthcare conglomerate’s stock worth $6,042,710,000 after purchasing an additional 1,747,337 shares in the last quarter. Capital Research Global Investors grew its position in shares of UnitedHealth Group by 126.9% during the 3rd quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock valued at $4,503,419,000 after purchasing an additional 7,293,009 shares in the last quarter. Dodge & Cox raised its position in shares of UnitedHealth Group by 8.6% in the third quarter. Dodge & Cox now owns 9,505,636 shares of the healthcare conglomerate’s stock worth $3,282,296,000 after buying an additional 755,076 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in UnitedHealth Group by 1.6% during the third quarter. Northern Trust Corp now owns 9,109,692 shares of the healthcare conglomerate’s stock valued at $3,145,577,000 after buying an additional 144,109 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Price Performance
Shares of UnitedHealth Group stock opened at $261.83 on Tuesday. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The company’s fifty day simple moving average is $289.00 and its two-hundred day simple moving average is $321.61. The firm has a market cap of $237.66 billion, a PE ratio of 19.85, a price-to-earnings-growth ratio of 1.19 and a beta of 0.41. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $606.36.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were issued a $2.21 dividend. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a yield of 3.4%. UnitedHealth Group’s payout ratio is 67.02%.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on UNH shares. Oppenheimer dropped their price target on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a research report on Wednesday, January 28th. Royal Bank Of Canada lowered their target price on shares of UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. Morgan Stanley cut their price target on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a research note on Friday, January 23rd. JPMorgan Chase & Co. cut their price objective on UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a report on Monday, February 2nd. Finally, Piper Sandler reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Tuesday, January 27th. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $372.13.
View Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Company Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
See Also
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
